PROLOR Biotech To Present At Jefferies 2013 Global Healthcare Conference

   PROLOR Biotech To Present At Jefferies 2013 Global Healthcare Conference

PR Newswire

NES-ZIONA, Israel, May 31, 2013

NES-ZIONA, Israel, May 31, 2013 /PRNewswire/ --PROLOR Biotech, Inc. (NYSE
MKT: PBTH), a clinical stage company developing next generation biobetter
therapeutic proteins, today announced that company management will give a
corporate presentation at the Jefferies 2013 Global Healthcare Conference,
being held at the Grand Hyatt Hotel in New York City. The presentation is
scheduled for June 4, 2013 at 4:30 pm ET.

A live webcast of the company's presentation will be available at the
Investors section of PROLOR's website at, or at An audio replay of the presentation will
be available on the PROLOR website approximately one hour after the
presentation and will be archived for at least 30 days.

The Jefferies 2013 Global Healthcare Conference will be held June 3-6, 2013.
For more information, visit

PROLOR Biotech, Inc. is a clinical stage biopharmaceutical company applying
unique technologies, including patented CTP technology and its long-acting
reversible-pegylation technology, primarily to develop longer-acting
proprietary versions of already approved therapeutic proteins that currently
generate billions of dollars in annual global sales. The CTP technology is
applicable to virtually all proteins. PROLOR is developing a long-acting
version of human growth hormone, which is currently being assessed in a Phase
III pivotal trial. It also is developing long-acting versions of Factor VIIa
and Factor IX for hemophilia and a GLP-1/Glucagon dual receptor agonist
peptide for diabetes and obesity, all of which are in preclinical development.
For more information, visit

Shai Novik, President           Barbara Lindheim
PROLOR Biotech, Inc.            BLL Partners
Tel: +1 866 644-7811            +1 212 584-2276


Press spacebar to pause and continue. Press esc to stop.